Basilea Pharmaceutica AG Share Price
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
16:31:22 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 53.10 CHF | +0.19% |
|
+3.31% | -2.93% |
| 08-05 | Swiss Market Index Extends Rally; Sandoz Shares Gain | MT |
| 08-05 | Basilea Pharmaceutica Bags Additional $5 Million Funding for Antibiotic Development | MT |
| Market Cap | 658M 809M 699M 598M 1.12B 77.25B 1.14B 7.71B 3.01B 38.74B 3.04B 2.97B 129B | P/E 2026 * |
13x | P/E 2027 * | 15.6x |
|---|---|---|---|---|---|
| Enterprise Value | 509M 626M 541M 463M 869M 59.79B 884M 5.97B 2.33B 29.98B 2.35B 2.3B 99.81B | EV / Sales 2026 * |
1.95x | EV / Sales 2027 * | 1.65x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | +0.19% | ||
| 1 week | +3.31% | ||
| Current month | +2.31% | ||
| 3 months | -3.80% | ||
| 6 months | -6.84% | ||
| Current year | -2.93% |
| 1 week | 51.8 |  | 53.6 |
| 1 month | 50.4 | | 53.6 |
| Current year | 47.8 | | 59.2 |
| 1 year | 44.7 | | 59.2 |
| 3 years | 32 | | 59.7 |
| 5 years | 29.55 | | 59.7 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 18/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 09/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 30/04/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 28/11/2011 |
| Chairman | 71 | 08/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 26/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/05/26 | Sell | -400 | 0.0030% | |||
| 25/02/26 | Fiscal year | 1,500 | 0.0113% | |||
| 20/02/26 | Sell | 600 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.19% | +3.31% | +0.76% | +25.98% | 809M | |
| -1.78% | -0.71% | +2.18% | +13.68% | 49.24B | |
| +0.85% | +2.98% | +464.76% | +579.26% | 43.3B | |
| -2.40% | +5.36% | +13.00% | +75.78% | 40.48B | |
| -2.01% | +1.82% | +24.41% | +7.65% | 39.75B | |
| -0.50% | +3.08% | +19.91% | +47.26% | 32.67B | |
| +0.38% | -1.08% | - | - | 16.23B | |
| -0.59% | -1.11% | +23.61% | +116.76% | 16.24B | |
| +0.49% | +0.80% | +5.45% | +22.29% | 14.04B | |
| -0.43% | +5.48% | +80.68% | +30.58% | 13.43B | |
| Average | -0.58% | +2.25% | +70.53% | +102.14% | 26.62B | |
| Weighted average by Cap. | -0.93% | +2.54% | +95.70% | +133.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 261M 320M 277M 237M 444M 30.59B 452M 3.05B 1.19B 15.34B 1.2B 1.18B 51.06B | 271M 333M 287M 246M 461M 31.75B 469M 3.17B 1.24B 15.92B 1.25B 1.22B 53B |
| Net income | 53.56M 65.83M 56.88M 48.62M 91.31M 6.29B 92.93M 627M 245M 3.15B 247M 242M 10.49B | 44.43M 54.61M 47.19M 40.34M 75.75M 5.21B 77.09M 520M 203M 2.61B 205M 201M 8.7B |
| Net Debt | -149M -183M -158M -135M -254M -17.46B -258M -1.74B -681M -8.76B -687M -672M -29.15B | -211M -260M -224M -192M -360M -24.79B -366M -2.47B -967M -12.43B -975M -954M -41.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | CHF 53.10 | +0.19% | 29,468 |
| 13/08/26 | CHF 53.00 | +0.76% | 18,048 |
| 12/08/26 | CHF 52.60 | +1.15% | 44,686 |
| 11/08/26 | CHF 52.00 | -0.19% | 31,420 |
| 10/08/26 | CHF 52.10 | +0.58% | 11,367 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
